×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

GE Healthcare Showcases Latest Version of Vivid E9 Cardiovascular Ultrasound at Heart Rhythm Society Meeting

May 09, 2012

Recently FDA-cleared Vivid E9 BT12 with new 4D TEE Transducer and Additional Efficiency Tools Help Enhance Workflow in the EP lab

business unit
tags
Press Release

GE Healthcare strengthens its commitment to electrophysiology with dose reduction technologies and advanced clinical applications

May 09, 2012

Waukesha, WI -- MAY 9, 2012 -- GE Healthcare announced today, during the Heart Rhythm Society's (HRS) 33rd Annual Scientific Sessions, a continued commitment to electrophysiology (EP) by delivering new technologies for ablation guidance, dose reduction, and signal optimization.

GE Healthcare also announced the extension of their current co-distribution agreement with Biosense Webster with a three-year roadmap development collaboration that aims to deliver tighter integration between their CardioLab* recording system and CARTO® 3 navigation system.

business unit
tags
Press Release

Phase 3 Results for GE Healthcare Imaging Agent Flutemetamol Presented at American Academy of Neurology Meeting

April 25, 2012


Results Show Similar Imaging Performance in Alzheimer's Disease Autopsy and Biopsy Studies

business unit
tags
Press Release

GE Healthcare Enhances Workflow in Echo Lab, OR and Cath Lab with Vivid E9 Cardiovascular Ultrasound, Now Including 4D TEE Transducer

April 25, 2012

Latest Version of Vivid E9 with 4D TEE Transducer and Additional Efficiency Tools Receives FDA Clearance

business unit
tags
Press Release

DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging Demonstrates Impact on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome

April 24, 2012

New data showing physician confidence in DaTscan diagnostic tool presented at 2012 American Academy of Neurology Meeting

business unit
tags
Press Release

GE Healthcare brings rapid cell characterization to the benchtop with launch of new image cytometry system

April 23, 2012

Cytell™ Image Cytometer designed for research use in cell health, phenotype and antibody assay analyses

Introduces simpler and faster way of working for researchers; frees up specialised cell analysis instruments

business unit
tags
Press Release

GE Healthcare to Develop Next Generation Compact Cyclotron and PET Tracer System for Global Markets

April 19, 2012

Joint Financing Agreement with Sweden's NXT2B may allow greater access to Cancer and Neurodegenerative Disease Diagnosis in Emerging and Developing Markets

business unit
tags
Press Release

GE Healthcare Announces Preliminary Phase 3 Results for Flutemetamol

April 11, 2012

All studies meet primary endpoints; full results to be reported later this year

business unit
tags
Press Release

GE Healthcare Launches New Version of Centricity EDI Services

April 11, 2012

Centricity EDI Processes 200MM Claims Per Year

business unit
tags
Press Release

GE Healthcare and Refine Technology sign supply and distribution agreement to support drive for continuous processing in biopharmaceutical manufacture

April 10, 2012

Chalfont St Giles, UK, and Pine Brook, NJ -- 10 April 2012 -- GE Healthcare, the healthcare business of GE (NYSE: GE) has signed a worldwide supply and distribution agreement with Refine Technology, a manufacturer and supplier of novel filtration systems for use in biopharmaceutical manufacturing. Under the terms of the agreement, GE Healthcare will supply Refine Technology with its innovative hollow fiber filtration cartridges for use with Refine Technology's ATF™ system.

business unit
tags
Subscribe to GE Healthcare